Search Results

Filter
  • 1-10 of  175,435 results for ""Oxaliplatin""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Oxaliplatin lipidated prodrug synergistically enhances the anti-colorectal cancer effect of IL12 mRNA.

  • Authors : Liu H; School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, 264005, China.; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, 264000, China.

Subjects: Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/administration & dosage ; Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/pharmacology ; Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/pharmacokinetics

  • Source: Drug delivery and translational research [Drug Deliv Transl Res] 2024 Nov; Vol. 14 (11), pp. 3186-3199. Date of Electronic Publication: 2024 Mar 08.Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Oxaliplatin-induced peripheral neuropathy with hepatic arterial versus intravenous infusion in metastatic colorectal cancer.

  • Authors : Valéry M; Département de Médecine Oncologique, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.; Tanguy ML

Subjects: Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/administration & dosage ; Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/adverse effects ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy

  • Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Sep 16; Vol. 32 (10), pp. 660. Date of Electronic Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.

  • Authors : Deng J; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Clinical Research Centre (CRC), Medical Pathology Centre (MPC), Cancer Early Detection and Treatment Centre (CEDTC), Translational Medicine Research Centre (TMRC), Chongqing University Three Gorges Hospital, Chongqing University, Wanzhou, Chongqing, China.

Subjects: Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/pharmacology ; Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/therapeutic use ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy

  • Source: EMBO molecular medicine [EMBO Mol Med] 2024 Sep; Vol. 16 (9), pp. 2080-2108. Date of Electronic Publication: 2024 Aug 05.Publisher: Wiley-Blackwell Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Mitotic Arrest Deficient 2 Like 1 Contributes to Colorectal Cancer Cell Migration, Invasion, and Oxaliplatin Resistance Through the Wnt/β-Catenin Pathway.

  • Authors : Ding X; Department of Gastroenterology, Yueyang Central Hospital, Yueyang, Hunan, People's Republic of China.; Zhou Y

Subjects: Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/pharmacology ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/metabolism ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology

  • Source: Chemical biology & drug design [Chem Biol Drug Des] 2024 Nov; Vol. 104 (5), pp. e70012.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print Cited Medium: Internet ISSN: 1747-0285

Record details

×
Academic Journal

Exploration for Blood Biomarkers of Human Long Non-coding RNAs Predicting Oxaliplatin-Induced Chronic Neuropathy Through iPS Cell-Derived Sensory Neuron Analysis.

  • Authors : Sakai A; Department of Pharmacology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8602, Japan. .; Yamada T

Subjects: Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/adverse effects ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/blood

  • Source: Molecular neurobiology [Mol Neurobiol] 2024 Sep; Vol. 61 (9), pp. 7168-7180. Date of Electronic Publication: 2024 Feb 19.Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Delivery of SiRNA-PD-L1 by attenuated Salmonella in combination with oxaliplatin in a hepatocellular carcinoma mouse model.

  • Authors : Chen P; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.; Chen J

Subjects: Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/therapeutic use ; Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/pharmacology ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Nov 15; Vol. 141, pp. 112892. Date of Electronic Publication: 2024 Aug 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

circ_0006089 facilitates gastric cancer progression and oxaliplatin resistance via miR-217/NRP1.

  • Authors : Zhou Y; Gastroenterology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China.; Zhang Q

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/genetics ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy

  • Source: Pathology, research and practice [Pathol Res Pract] 2024 Nov; Vol. 263, pp. 155596. Date of Electronic Publication: 2024 Sep 22.Publisher: Gustav Fischer Verlag Country of Publication: Germany NLM ID: 7806109 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Quality of life and somatic physical function of patients with colorectal cancer who underwent oxaliplatin-based systemic chemotherapy: a prospective study.

  • Authors : Tuğral A; Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Izmir Bakırçay University, Izmir, Turkey. .; Kebabcı E

Subjects: Quality of Life* ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/administration & dosage

  • Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Oct 18; Vol. 32 (11), pp. 734. Date of Electronic Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Chitosan-graphene quantum dot-based molecular imprinted polymer for oxaliplatin release.

  • Authors : Farshi Azhar F; Department of Chemistry, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran.; Ahmadi M

Subjects: Chitosan*/Chitosan*/Chitosan*/chemistry ; Graphite*/Graphite*/Graphite*/chemistry ; Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/chemistry

  • Source: Journal of biomaterials science. Polymer edition [J Biomater Sci Polym Ed] 2024 Oct; Vol. 35 (14), pp. 2115-2136. Date of Electronic Publication: 2024 Jun 17.Publisher: Taylor and Francis Country of Publication: England NLM ID: 9007393 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cold-associated laryngopharyngeal dysesthesia syndrome after oxaliplatin treatment.

  • Authors : Babacan A; University of Health Sciences, Ankara Dr Abdurrahman Yurtarslan Oncology Training, and Research Hospital, Ankara, Turkey.

Subjects: Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/adverse effects ; Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/administration & dosage ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects

  • Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Oct; Vol. 30 (7), pp. 1245-1248. Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  175,435 results for ""Oxaliplatin""